About Peptide Proof
Rigorous. Independent. Evidence-based.
Our Mission
Peptide Proof exists because peptide science deserves rigorous, independent coverage — the kind of scrutiny that major journals apply to research articles, applied to the news, trends, and market forces shaping the field.
We track peptide science across the full translational arc: from computational discovery and structural biology, through preclinical validation and clinical development, to manufacturing, regulatory approval, and market dynamics. Our coverage is data-driven, citation-backed, and free from commercial influence.
Editorial Standards
Every article published on Peptide Proof adheres to three principles:
Primary Sources
We cite original research, regulatory filings, clinical trial registrations, and company disclosures — not press releases. Every factual claim in our reporting is traceable to a verifiable source.
No Sponsorship
We do not accept payment for coverage. No company, institution, or individual can buy favorable coverage or suppress unfavorable reporting. Our editorial judgment is not for sale.
Expert Review
Technical articles are reviewed by domain experts before publication. When we make errors, we correct them transparently with a dated correction notice at the top of the article.
Who We Are
Peptide Proof is written and edited by researchers and analysts with backgrounds in peptide chemistry, molecular pharmacology, biotech investment, and pharmaceutical manufacturing. Our contributors have trained at academic institutions, worked in drug discovery, and covered the life sciences as journalists and analysts.
We believe that the best science journalism combines deep domain expertise with editorial independence. Our contributors understand the difference between a Kd and an IC50, know what a Ramachandran plot reveals, and can read a patent filing without being misled by the abstract.
Contact
We welcome tips, corrections, and thoughtful criticism. Reach us at editorial@peptide-proof.com.
For contributors: we accept pitches for reported features, technical analyses, and expert commentary. Please include a brief summary of your proposed piece and your relevant expertise.
Last updated: June 2026